Insider trading

Period: 120 months Stock: SPRY Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

49 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

49 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

49 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

49 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
49 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
49 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

49 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Nov 2025
Chakma Justin Chief Business Officer
Sold at will 2×
$1.48M 166,380 at 8.87
100%
Sold half or more
27 Jun 2025
Flynn James E 10% owner · indirect
Sold at will 2×
$13.66M 740,149 at 18.46
13.2%
Not planned
20 May 2025
SAUNDERS BRENT L Director
Sold at will
$1.71M 120,000 at 14.25
100%
Sold half or more
20 May 2025
Fitzpatrick Alexander A Chief Legal Officer
Sold at will
$1.45M 102,969 at 14.10
53.5%
Sold half or more
17 Dec 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.17M 100,000 at 11.67
8.3%
Planned (10b5-1)
17 Dec 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.17M 100,000 at 11.67
8.3%
Planned (10b5-1)
12 Dec 2024
Chakma Justin Chief Business Officer
Sold at will
$1.44M 117,333 at 12.27
46.2%
Not planned
10 Dec 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.32M 100,000 at 13.16
8.0%
Planned (10b5-1)
10 Dec 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.32M 100,000 at 13.16
8.0%
Planned (10b5-1)
3 Dec 2024
Shawver Laura Director
Sold on a plan
$1.17M 87,984 at 13.26
29.5%
Planned (10b5-1)
2 Dec 2024
Shawver Laura Director
Sold on a plan 2×
$1.32M 97,244 at 13.56
31.6%
Planned (10b5-1)
19 Nov 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.39M 100,000 at 13.95
7.7%
Planned (10b5-1)
19 Nov 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.39M 100,000 at 13.95
7.7%
Planned (10b5-1)
12 Nov 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 4×
$1.68M 100,000 at 16.85
7.4%
Planned (10b5-1)
12 Nov 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 4×
$1.68M 100,000 at 16.85
7.4%
Planned (10b5-1)
11 Nov 2024
Flynn James E 10% owner · indirect
Sold at will 4×
$9.53M 528,456 at 18.04
9.1%
Not planned
15 Oct 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 3×
$1.49M 100,000 at 14.88
7.2%
Planned (10b5-1)
15 Oct 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 3×
$1.49M 100,000 at 14.88
7.2%
Planned (10b5-1)
8 Oct 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.38M 100,000 at 13.83
6.9%
Planned (10b5-1)
8 Oct 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.38M 100,000 at 13.83
6.9%
Planned (10b5-1)
17 Sep 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.29M 100,000 at 12.93
6.7%
Planned (10b5-1)
17 Sep 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.29M 100,000 at 12.93
6.7%
Planned (10b5-1)
10 Sep 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.15M 100,000 at 11.50
6.7%
Planned (10b5-1)
10 Sep 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.15M 100,000 at 11.50
6.7%
Planned (10b5-1)
26 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will
$1.09M 83,695 at 13.00
100%
Sold half or more
26 Aug 2024
Thompson Peter A. Director · indirect
Sold at will
$1.09M 83,695 at 13.00
100%
Sold half or more
22 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will
$5.07M 391,482 at 12.94
71.9%
Sold half or more
22 Aug 2024
Thompson Peter A. Director · indirect
Sold at will
$5.07M 391,482 at 12.94
71.9%
Sold half or more
21 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will 2×
$5.53M 407,700 at 13.56
42.8%
Not planned
21 Aug 2024
Thompson Peter A. Director · indirect
Sold at will 2×
$5.53M 407,700 at 13.56
42.8%
Not planned
20 Aug 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 6×
$1.50M 100,000 at 15.03
6.3%
Planned (10b5-1)
20 Aug 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 6×
$1.50M 100,000 at 15.03
6.3%
Planned (10b5-1)
13 Aug 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 4×
$1.25M 100,000 at 12.48
6.5%
Planned (10b5-1)
13 Aug 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 4×
$1.25M 100,000 at 12.48
6.5%
Planned (10b5-1)
16 Jul 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.14M 100,000 at 11.40
6.1%
Planned (10b5-1)
16 Jul 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.14M 100,000 at 11.40
6.1%
Planned (10b5-1)
27 Mar 2024
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$4.95M 505,954 at 9.79
5.4%
26 Mar 2024
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$4.37M 457,745 at 9.55
5.1%
25 Mar 2024
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$3.96M 437,600 at 9.06
5.1%
21 Sep 2023
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought 2×
$8.18M 2,700,000 at 3.03
46.1%
+46% of stake
29 Aug 2023
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$23.25M 3,750,000 at 6.20
178%
First buy on file
29 Aug 2023
Thompson Peter A. Director · indirect
Bought
$3.10M 500,000 at 6.20
6.6%
29 Aug 2023
ORBIMED ADVISORS LLC Director · indirect
Bought
$3.10M 500,000 at 6.20
6.6%
8 Dec 2020
ORBIMED ADVISORS LLC Director · indirect
Bought
$20.00M 952,377 at 21.00
opened
First buy on file
8 Dec 2020
Thompson Peter A. Director · indirect
Bought
$20.00M 952,377 at 21.00
opened
First buy on file
8 Dec 2020
ORBIMED ADVISORS LLC Director · indirect
Bought
$5.00M 238,100 at 21.00
88.4%
First buy on file
8 Dec 2020
Thompson Peter A. Director · indirect
Bought
$5.00M 238,100 at 21.00
88.4%
First buy on file
8 Dec 2020
Schroeder Thilo Director · indirect
Bought
$5.00M 238,096 at 21.00
opened
First buy on file
8 Dec 2020
ROOT JONATHAN D Director
Bought
$2.00M 95,238 at 21.00
opened
First buy on file
Showing 1–49 of 49.